5 results
Low-molecular-weight heparin administered by subcutaneous catheter is a safe and effective anti-coagulation regimen in selected inpatient infants and children with complex congenital heart disease
- Part of
-
- Journal:
- Cardiology in the Young / Volume 31 / Issue 9 / September 2021
- Published online by Cambridge University Press:
- 16 February 2021, pp. 1439-1444
-
- Article
- Export citation
“The Other Side of the Coin”: Hemorrhagic Stroke in Congenital Hypofibrinogenemia
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 46 / Issue 5 / September 2019
- Published online by Cambridge University Press:
- 17 May 2019, pp. 635-636
-
- Article
-
- You have access
- HTML
- Export citation
Ischemic Strokes in a Man with Congenital Afibrinogenemia
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 45 / Issue 5 / September 2018
- Published online by Cambridge University Press:
- 18 July 2018, pp. 590-592
-
- Article
-
- You have access
- HTML
- Export citation
Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD
-
- Journal:
- Cardiology in the Young / Volume 28 / Issue 5 / May 2018
- Published online by Cambridge University Press:
- 01 March 2018, pp. 715-718
-
- Article
- Export citation
Early Anti-Coagulation after Ischemic Stroke due to Atrial Fibrillation is Safe and Prevents Recurrent Stroke
- Part of
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 42 / Issue 2 / March 2015
- Published online by Cambridge University Press:
- 05 March 2015, pp. 92-95
-
- Article
-
- You have access
- HTML
- Export citation